Filing Details

Accession Number:
0000899243-23-019969
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-18 16:30:09
Reporting Period:
2023-10-16
Accepted Time:
2023-10-18 16:30:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1805387 Cerevel Therapeutics Holdings Inc. CERE () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1040508 Bain Capital Investors Llc 200 Clarendon Street
Boston MA 02116
No No Yes No
1706270 Bain Capital Fund Xii, Lp 200 Clarendon Street
Boston MA 02116
No No Yes No
1829130 Bcpe Perception Gp, Llc 200 Clarendon Street
Boston MA 02116
No No Yes No
1829166 Bc Perception Holdings, Lp 200 Clarendon Street
Boston MA 02116
No No Yes No
1830424 Bain Capital Partners Xii, Llc 200 Clarendon Street
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-10-16 5,480,052 $22.81 65,679,781 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
Footnotes
  1. Represents shares of the Issuer's common stock held directly by BC Perception Holdings, LP ("BC Perception"). Bain Capital Fund XII, L.P. ("Fund XII") is the sole member of BCPE Perception GP, LLC ("Perception GP"), which is the general partner of BC Perception. Bain Capital Investors, LLC ("BCI") is the manager of Bain Capital Partners XII, LLC ("Partners XII" and, together with BCI, BC Perception, Fund XII and Perception GP, the "Bain Capital Entities"), which is the general partner of Fund XII. As a result, each of the Bain Capital Entities may be deemed to share voting and dispositive power with respect to the shares of the Issuer's common stock held by BC Perception. Each of the Bain Capital Entities disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein.
  2. On October 16, 2023, BC Perception purchased 5,480,052 shares of the Issuer's common stock at a price of $22.81 per share in an underwritten public offering.